The monograph contains reliable results of immunological imbalance in migraine in children and adolescents, as well as data on the effectiveness of the inclusion of immunomodulatory drugs in migraine in standard therapeutic measures, which will reduce the risk of progression and chronicity of cephalalgia.The monograph is intended for neurologists and doctors of allied specialties, as well as for graduate students and clinical residents.